Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma.
about
Preclinical development of CAT-354, an IL-13 neutralizing antibody, for the treatment of severe uncontrolled asthmaT-bet polymorphisms are associated with asthma and airway hyperresponsivenessThe gene encoding interleukin-13: a susceptibility locus for asthma and related traitsThe squamous cell carcinoma antigen 2 inhibits the cysteine proteinase activity of a major mite allergen, Der p 1Differential effect of phosphodiesterase inhibitors on IL-13 release from peripheral blood mononuclear cellsIdentification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammationLebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies.IL-13 expression by blood T cells and not eosinophils is increased in asthma compared to non-asthmatic eosinophilic bronchitis.Cytokines in asthma.Neutralisation of interleukin-13 in mice prevents airway pathology caused by chronic exposure to house dust mite.Natural killer T cell sensitization during neonatal respiratory syncytial virus infection induces eosinophilic lung disease in re-infected adult miceTh2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammationOral administration of heat-inactivated Lactobacillus plantarum K37 modulated airway hyperresponsiveness in ovalbumin-sensitized BALB/c mice.Advances in the immunobiology of eosinophils and their role in disease.Antigen presentation and stimulation of the immune system in human airways.Bronchial epithelial cells produce IL-5: implications for local immune responses in the airways.Aberrant production of IL-13 by T cells promotes exocrinopathy in Id3 knockout mice.Anisakis pegreffii-induced airway hyperresponsiveness is mediated by gamma interferon in the absence of interleukin-4 receptor alpha responsiveness.Biochemical and functional characterization of human transmembrane tryptase (TMT)/tryptase gamma. TMT is an exocytosed mast cell protease that induces airway hyperresponsiveness in vivo via an interleukin-13/interleukin-4 receptor alpha/signal trans12/15-lipoxygenase is an interleukin-13 and interferon-γ counterregulated-mediator of allergic airway inflammation.Human airway musculature on a chip: an in vitro model of allergic asthmatic bronchoconstriction and bronchodilation.Expression of IL-4/IL-13 receptors in differentiating human airway epithelial cells.Effects of omalizumab in non-atopic asthma: results from a Spanish multicenter registry.The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge.The role of periostin in tissue remodeling across health and disease.Chemokines and their receptors guiding T lymphocyte recruitment in lung inflammation.Interleukin-5: a novel target for asthma therapy.Molecular mechanisms of atopyDecreased prevalence of asthma among children with high exposure to cat allergen: relevance of the modified Th2 responseDifferences in allergen-induced T cell activation between allergic asthma and rhinitis: Role of CD28, ICOS and CTLA-4New immune pathways from chronic post-viral lung diseaseAtopic dermatitis patients carrying G allele in -1082 G/A IL-10 polymorphism are predisposed to higher serum concentration of IL-10.Interleukin-13: prospects for new treatments.Regulation of IL-13 synthesis in human lymphocytes: implications for asthma therapy.Functional characterization and biomarker identification in the Brown Norway model of allergic airway inflammationLong-term benefits of omalizumab in a patient with severe non-allergic asthmaInterleukin-13 and leukotrienes: an intersection of pathogenetic schema.Selective stimulation of IL-4 receptor on smooth muscle induces airway hyperresponsiveness in mice.Adaptive cytokine production in early life differentially predicts total IgE levels and asthma through age 5 years.Expression of surfactant protein D in airways of asthmatics and interleukin-13 modulation of surfactant protein D in human models of airway epithelium.
P2860
Q24620510-9D21FF2D-B5B5-4BFE-BA1C-2E2F8871D347Q24650376-578FA025-E5F4-469C-8D7F-39495D29938EQ24791072-9669A4EB-9908-4DDF-A5E5-3BA0961E4203Q28186148-3AA6E37D-BA53-4C98-A528-4119EAD64321Q28365971-07F7DC3B-2B54-499A-8231-DEA7D96E8387Q28587850-79FA505A-2570-4B68-9287-2CC7BE3F49D7Q30957004-5F62B708-8024-44C2-B0D1-8E587B904642Q33481984-743D54A1-BB50-4FF6-A215-4F90E60EF4FCQ33717312-A51E74E4-DCD3-436D-A978-C454E355A23BQ33722148-10A4AF1C-CB64-486F-B05C-A09596D56FBDQ33751615-63D7A6AB-6777-4B16-A06B-778117C22162Q33753434-26D6D143-CC89-49D8-9A55-7DB92B52495EQ33769067-DCE1DCA6-582D-46C3-85E7-AC7321605EBBQ33773048-C7255008-EA8A-4A74-B8FF-1F2693C7BCDAQ33775585-A9D023EB-7ABB-4173-A0E2-678DF802981FQ33987064-BE931A2D-F529-4667-AD6B-337C8FF5B6C9Q34022774-7A364587-1F01-4781-8EA2-4C79FA97AE8AQ34119421-01CAFB69-3AAA-42AD-A630-66F41C6E9025Q34145976-E0CCD9DB-6851-469F-A33C-A4D2D6630F49Q34189821-7626241E-04F0-4E5E-B28E-0871DA15CECBQ34205274-89CAE2BC-B2E5-4CE3-8109-B49A6DE68AB6Q34305394-32361297-3113-49B2-B9C2-4C5361750722Q34324456-CB5B62FD-6CE2-46FD-9FF8-33F910D81BC4Q34376674-C4204C5A-FDBA-48B0-B397-21304EAD717AQ34379268-6859E04C-1663-4E6B-B411-6FC20C6A979FQ34416618-F1F194C7-1376-48B4-BDAC-0AA72B393C97Q34451982-02658E3F-89B0-460F-AA9E-77AFCD7CB856Q34510796-A6B7D37B-964C-4785-960A-55AF893CDEF8Q34510803-D02E6C26-6F4A-4812-B8B7-6BC0592FEA6EQ34638212-A80756FA-A05C-4F5E-9132-06E4982ED5BEQ34692122-146FB7FE-65F2-4B87-B95E-DD8DF47811F2Q34974365-36738B51-0326-4F49-A90E-6D00001C440AQ35010562-99213672-A622-4512-8E5F-76B6588B4C46Q35044321-616AA3A9-98A9-4E4D-A8CA-B71BC9F1FC7BQ35044590-1FE94E60-DC45-4404-A349-F645D8896E9DQ35078215-29B046D8-0229-4D4D-BAAA-CE1321C4991CQ35091277-DDDE09F9-C9E5-4E0C-B322-B5CC08BD0B68Q35102219-5F13C662-78B1-4FD1-818B-C7127D6377B7Q35146117-46B2A00C-18C0-4E2E-A7C3-BFD3CD7AFD46Q35155342-6D882AAF-FC4A-40A8-B608-2C89E933E541
P2860
Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Elevated expression of messeng ...... onatopic subjects with asthma.
@ast
Elevated expression of messeng ...... onatopic subjects with asthma.
@en
Elevated expression of messeng ...... onatopic subjects with asthma.
@nl
type
label
Elevated expression of messeng ...... onatopic subjects with asthma.
@ast
Elevated expression of messeng ...... onatopic subjects with asthma.
@en
Elevated expression of messeng ...... onatopic subjects with asthma.
@nl
prefLabel
Elevated expression of messeng ...... onatopic subjects with asthma.
@ast
Elevated expression of messeng ...... onatopic subjects with asthma.
@en
Elevated expression of messeng ...... onatopic subjects with asthma.
@nl
P2093
P1476
Elevated expression of messeng ...... nonatopic subjects with asthma
@en
P2093
C J Corrigan
S R Durham
P304
P356
10.1016/S0091-6749(97)70028-9
P407
P577
1997-05-01T00:00:00Z